Soleno Therapeutics, Inc. (SLNO): Price and Financial Metrics
SLNO Price/Volume Stats
| Current price | $39.91 | 52-week high | $53.82 |
| Prev. close | $40.14 | 52-week low | $3.16 |
| Day low | $39.44 | Volume | 176,267 |
| Day high | $40.74 | Avg. volume | 299,273 |
| 50-day MA | $43.55 | Dividend yield | N/A |
| 200-day MA | $28.11 | Market Cap | 1.30B |
SLNO Stock Price Chart Interactive Chart >
Soleno Therapeutics, Inc. (SLNO) Company Bio
Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The companys lead candidate, diazoxide choline controlled-release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development. It also markets medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns; and NeoPip T-piece resuscitator and related consumables, which deliver consistent pre-set inspiratory pressure and positive end-expiratory pressures, as well as temperature probes, scales, surgical tables, and patient surfaces. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. May 2017. Soleno Therapeutics, Inc. was founded in 1999 and is based in Redwood City, California.
Latest SLNO News From Around the Web
Below are the latest news stories about SOLENO THERAPEUTICS INC that investors may wish to consider to help them evaluate SLNO as an investment opportunity.
Why Soleno Therapeutics Stock Ticked Higher on ThursdayThe latest pundit take on the stock provided a good reason for bulls to snap it up. |
Growth Stocks Under $50 for December 2023These are seven of the best-performing growth stocks for December 2023 based on above-average returns. |
Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023These three stocks to take profits on rallied more than 200% this year. |
3 Stock Winners That Are Up 500% or More in 2023If you want to find 2023's top-performing stock, check out these companies that returned 500% or more since January |
Insider Sell Alert: CEO Bhatnagar Anish Unloads 93,408 Shares of Soleno Therapeutics Inc (SLNO)In a notable insider sell transaction, CEO Bhatnagar Anish of Soleno Therapeutics Inc (NASDAQ:SLNO) parted with 93,408 shares of the company on December 11, 2023. |
SLNO Price Returns
| 1-mo | -4.22% |
| 3-mo | -14.76% |
| 6-mo | 77.22% |
| 1-year | 978.65% |
| 3-year | 123.59% |
| 5-year | 34.38% |
| YTD | -0.84% |
| 2023 | 1,932.83% |
| 2022 | -67.80% |
| 2021 | -78.76% |
| 2020 | -34.35% |
| 2019 | 71.93% |
Loading social stream, please wait...